Interview with Dr. Ana Falcon from BIOVEXO partner DOMCA
Young Researcher Spotlight: Dr. Ana Falcon Shares Insights into BIOVEXO’s Fight Against Xylella
As the BIOVEXO project enters its final stretch toward completion at the end of 2025, we’re excited to share a recent interview that shines a light on the critical work being done behind the scenes — and the young scientists driving innovation forward.
In a new six-minute video interview, Dr. Ana Falcon, a promising researcher at DOMCA, discusses her journey from academic research to real-world impact. Dr. Falcon’s PhD thesis directly aligns with the mission of BIOVEXO: developing biocontrol solutions to combat Xylella fastidiosa, a devastating plant pathogen threatening olive and almond trees across the Mediterranean.
In the interview, Dr. Falcon offers a fascinating look into her research on organosulfur compounds — natural bioactive molecules that DOMCA is testing as a more sustainable alternative to synthetic chemicals for crop protection and stimulation. She shares how her interest in these compounds grew from their potential not just to suppress pathogens like Xylella, but also to boost plant resilience overall.
One of the most intriguing parts of the conversation is Dr. Falcon’s account of unexpected findings that emerged during her studies. While she anticipated antimicrobial properties, she also uncovered interesting synergistic effects when organosulfur compounds were combined with other natural substances. These discoveries could pave the way for more holistic plant protection strategies.
Of course, safety is key. Dr. Falcon explains how extensive environmental assessments are conducted to ensure that these compounds, when applied in the field, pose no risk to beneficial insects, soil health, or surrounding ecosystems. This commitment to sustainability is a cornerstone of the BIOVEXO approach.
The interview also touches on the broader impact of this research. While Xylella remains a major threat, the solutions being developed by DOMCA and other BIOVEXO partners could have far-reaching benefits for protecting crops from a range of bacterial pathogens. Dr. Falcon expresses optimism that their work will offer farmers viable tools to manage disease without relying on harmful chemicals.
Looking ahead, Dr. Falcon outlines the next steps for the BIOVEXO project — final field validations, preparations towards product development, and knowledge-sharing across Europe. It’s an exciting and busy period, as the project team works to translate years of research into real-world application before the project wraps up in late 2025.
Don’t miss the full interview – in just six minutes, you’ll gain a deeper understanding of the science behind BIOVEXO and the passionate people pushing it forward.
